Eisai

4523.TSE

33.56 USD

0.49

+1.48%

Overview

Last close

33.56 usd

Market cap

9.46B usd

52 week high

41.10 usd

52 week low

24.09 usd

Target price

31.81 usd

Valuation

P/E

29.94

Forward P/E

32.6797

Price/Sales

1.828

Price/Book Value

1.6607

Enterprise Value

8.90B usd

EV/Revenue

1.7254

EV/EBITDA

12.6098

Key financials

Revenue TTM

5.18B usd

Gross Profit TTM

4.03B usd

EBITDA TTM

570.46M usd

Earnings per Share

1.12 usd

Dividend

1.03 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.